What is HC Wainwright's Estimate for AMPX FY2026 Earnings?

Key Points

• HC Wainwright lowered its FY2026 EPS estimate for Amprius Technologies to a loss of $0.07 per share, down from its prior forecast of a $0.06 loss. That matches the current consensus estimate for the year.
• The firm also projected FY2027 EPS of $0.01 and FY2028 EPS of $0.18, suggesting a gradual path toward profitability.
• Amprius recently reported a Q1 EPS miss at $(0.04) versus estimates of $(0.02), though revenue of $28.54 million came in above expectations.

Amprius Technologies, Inc. (NYSE:AMPX - Free Report) - Equities researchers at HC Wainwright reduced their FY2026 EPS estimates for shares of Amprius Technologies in a research note issued on Friday, May 8th. HC Wainwright analyst A. Dayal now forecasts that the company will earn ($0.07) per share for the year, down from their prior forecast of ($0.06). The consensus estimate for Amprius Technologies' current full-year earnings is ($0.07) per share. HC Wainwright also issued estimates for Amprius Technologies' FY2027 earnings at $0.01 EPS and FY2028 earnings at $0.18 EPS.

Amprius Technologies (NYSE:AMPX - Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.02). The company had revenue of $28.54 million during the quarter, compared to the consensus estimate of $25.72 million. Amprius Technologies had a negative net margin of 43.98% and a negative return on equity of 17.48%.

AMPX has been the subject of several other research reports. Northland Securities set a $24.00 price objective on shares of Amprius Technologies in a research report on Monday. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Monday, April 20th. Craig Hallum raised their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a research report on Friday, March 6th. Cantor Fitzgerald raised their price objective on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a research report on Friday, March 6th. Finally, Needham & Company LLC restated a "buy" rating and set a $20.00 price objective on shares of Amprius Technologies in a research report on Tuesday, March 10th. Eight analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $20.25.

Amprius Technologies Trading Up 6.1%

NYSE:AMPX opened at $17.72 on Tuesday. Amprius Technologies has a twelve month low of $2.34 and a twelve month high of $22.80. The company has a 50-day moving average of $17.77 and a 200-day moving average of $13.31. The firm has a market cap of $2.43 billion, a price-to-earnings ratio of -59.05 and a beta of 2.20.

Insider Activity

In other Amprius Technologies news, Director Wen Hsuan Hsieh sold 413,146 shares of the company's stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the completion of the sale, the director directly owned 44,444 shares of the company's stock, valued at approximately $819,547.36. This represents a 90.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kang Sun sold 1,500,000 shares of the company's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the sale, the director directly owned 1,342,400 shares of the company's stock, valued at $21,357,584. This represents a 52.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,539,829 shares of company stock valued at $42,323,376 over the last ninety days. Corporate insiders own 12.90% of the company's stock.

Institutional Trading of Amprius Technologies

A number of hedge funds have recently bought and sold shares of the company. AlphaCentric Advisors LLC lifted its stake in Amprius Technologies by 20.0% during the first quarter. AlphaCentric Advisors LLC now owns 60,000 shares of the company's stock valued at $1,012,000 after buying an additional 10,000 shares in the last quarter. KBC Group NV purchased a new stake in Amprius Technologies during the first quarter valued at about $57,000. Swiss National Bank lifted its stake in Amprius Technologies by 4.7% during the first quarter. Swiss National Bank now owns 232,400 shares of the company's stock valued at $3,918,000 after buying an additional 10,400 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Amprius Technologies by 700.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 431,398 shares of the company's stock valued at $6,695,000 after buying an additional 377,485 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its stake in Amprius Technologies by 60.9% during the first quarter. Geneos Wealth Management Inc. now owns 17,140 shares of the company's stock valued at $289,000 after buying an additional 6,490 shares in the last quarter. 5.04% of the stock is owned by hedge funds and other institutional investors.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised its Q4 2027 EPS estimate for Amprius Technologies to $0.03 from $0.02, signaling slightly better profitability expectations ahead. Northland Securities estimate update
• Positive Sentiment: Northland also lifted its FY2028 EPS forecast to $0.23, reinforcing optimism that AMPX could move further into the black over time. Northland Securities FY2028 estimate update
• Neutral Sentiment: Northland trimmed its Q2 2027 EPS estimate to $0.00 from $0.01 and kept its Q4 2026 view at a small loss, showing the near-term path remains uneven. Northland Securities near-term estimate update
• Neutral Sentiment: HC Wainwright lowered its FY2026 and FY2027 earnings estimates, while still projecting eventual profitability, which points to mixed sentiment rather than a clear negative catalyst. HC Wainwright estimate update
• Neutral Sentiment: The consensus full-year EPS estimate remains at a loss of $0.07, so the company is still expected to lose money in the current year despite better long-term forecasts. Consensus estimate

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.